Comparative effects of ultra-short-acting β1-blockers on voltage-gated tetrodotoxin-resistant Na+ channels in rat sensory neurons

European Journal of Anaesthesiology

Volumn 26, Issue 3, 2009, Pages 196-200

  Tanahashi, Shigeaki ^a   Iida, Hiroki ^a   Dohi, Shuji ^a   Oda, Akiyoshi ^a   Osawa, Yoko ^a   Yamaguchi, Shinobu ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

Esmolol; Landiolol; Patch clamp method; Tetrodotoxin resistant Na+ channels

Indexed keywords

ESMOLOL; LANDIOLOL; PENTOBARBITAL; SODIUM CHANNEL; TETRODOTOXIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DRUG DERIVATIVE; MORPHOLINE DERIVATIVE; PROPANOLAMINE DERIVATIVE; UREA;

ANALGESIA; ANIMAL CELL; ARTICLE; CELL MEMBRANE; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; IC 50; MEMBRANE CURRENT; NOCICEPTION; NONHUMAN; PAIN; PATCH CLAMP; RAT; SENSORY NERVE CELL; SPINAL GANGLION; STEADY STATE; ANIMAL; CHANNEL GATING; DRUG EFFECT; DRUG RESISTANCE; ELECTROPHYSIOLOGY; KINETICS; MALE; METABOLISM; SENSORY RECEPTOR; SPRAGUE DAWLEY RAT; TIME;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; DRUG RESISTANCE; ELECTROPHYSIOLOGICAL PHENOMENA; ION CHANNEL GATING; KINETICS; MALE; MORPHOLINES; PATCH-CLAMP TECHNIQUES; PROPANOLAMINES; RATS; RATS, SPRAGUE-DAWLEY; SENSORY RECEPTOR CELLS; SODIUM CHANNELS; TETRODOTOXIN; TIME FACTORS; UREA;

EID: 65349130027     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0b013e32831ac268     Document Type: Article

References (25)

1. Iguchi S, Iwamura H, Nishizaki M, et al. Development of a highly cardioselective ultra short-acting β-blocker, ONO-1101. Chem Pharm Bull 1992; 40: 1462-1469.
2. Akopian AN, Souslova V, England S, et al. The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways. Nat Neurosci 1999; 2: 541-548.
3. Fischer W. Anticonvulsant profile and mechanism of action of propranolol and its two enantiomers. Seizure 2002; 11: 285-302.
4. Kawano T, Eguchi S, Iseki A, Oshita S. Effects of landiolol on cardiovascular responses, bispectral index and body movement during endotracheal intubation. Masui 2005; 54: 610-614.
5. Johansen JW, Flaishon R, Sebel PS. Esmolol reduces anesthetic requirement for skin incision during propofol/nitrous oxide/morphine anesthesia. Anesthesiology 1997; 87: 461-462.
6. Davidson EM, Doursout MF, Szmuk P, Chelly JE. Antinociceptive and cardiovascular properties of esmolol following formalin injection in rats. Can J Anaesth 2001; 48: 59-64.
7. Tanahashi S, Iida H, Oda A, et al. Effects of ifenprodil on voltage-gated tetrodotoxin-resistant Naβ channels in rat sensory neurons. Eur J Anaesthesiol 2007; 24: 782-788.
8. Oda A, Ohashi H, Komori S, et al. Characteristics of ropivacaine block of Naβ channels in rat dorsal root ganglion neurons. Anesth Analg 2000; 91: 1213-1220.
9. Song JH, Huang CS, Nagata K, et al. Differential action of riluzole on tetrodotoxin-sensitive and tetrodotoxin-resistant sodium channels. J Pharmacol Exp Ther 1997; 282: 707-714.
10. Wagner LE 2nd, Eaton M, Sabnis SS, Gingrich KJ. Meperidine and lidocaine block of recombinant voltage-dependent Naβ channels: evidence that meperidine is a local anesthetic. Anesthesiology 1999; 91: 1481-1490.
11. Kim YS, Shin YK, Lee C, Song J. Block of sodium currents in rat dorsal root ganglion neurons by diphenhydramine. Brain Res 2000; 881: 190-198.
12. Volz-Zang C, Eckrich B, Jahn P, et al. Esmolol, an ultrashort-acting, selective beta 1-adrenoceptor antagonist: pharmacodynamic and pharmacokinetic properties. Eur J Clin Pharmacol 1994; 46: 399-404.
13. Atarashi H, Kuruma A, Yashima M, et al. Pharmacokinetics of landiolol hydrochloride, a new ultra-short-acting beta-blocker, in patients with cardiac arrhythmias. Clin Pharmacol Ther 2000; 68: 143-150.
14. Bethge EW, Bohuslavizki KH, Hansel W, et al. Effects of some potassium channel blockers on the ionic currents in myelinated nerve. Gen Physiol Biophys 1991; 10: 225-244.
15. Stanley TH, de Lange S, Boscoe MJ, de Bruijn N. The influence of chronic preoperative propranolol therapy on cardiovascular dynamics and narcotic requirements during operation in patients with coronary artery disease. Can Anaesth Soc J 1982; 29: 319-324.
16. Amar D, Shamoon H, Frishman WH, et al. Effects of labetalol on perioperative stress markers and isoflurane requirements. Br J Anaesthol 1991; 67: 296-301.
17. Johansen JW, Schneider G, Windsor AM, Sebel PS. Esmolol potentiates reduction of minimum alveolar isoflurane concentration by alfentanil. Anesth Analg 1998; 87: 671-676.
18. Orme R, Leslie K, Umranikar A, Ugoni A. Esmolol and anesthetic requirement for loss of responsiveness during propofol anesthesia. Anesth Analg 2002; 94: 112-116.
19. Menigaux C, Guignard B, Adam F, et al. Esmolol prevents movement and attenuates the BIS response to orotracheal intubation. Br J Anaesth 2002; 89: 857-862.
20. Smith I, Van Hemelrijck J, White PF. Efficacy of esmolol versus alfentanil as a supplement to propofol-nitrous oxide anesthesia. Anesth Analg 1992; 74: 776-777.
21. Zaugg M, Tagliente T, Lucchinetti E, et al. Beneficial effects from betaadrenergic blockade in elderly patients undergoing noncardiac surgery. Anesthesiology 1999; 91: 1674-1686.
22. Yaksh TL. Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing. Pharmacol Biochem Behav 1985; 22: 845-858.
23. Mitrovic I, Margeta-Mitrovic M, Bader S, et al. Contribution of GIRK 2-mediated postsynaptic signaling to opiate and alpha 2-adrenergic analgesia and analgesic sex differences. Proc Natl Acad Sci USA 2003; 100: 271-276.
24. Gorczynski RJ. Basic pharmacology of esmolol. Am J Cardiol 1985; 56: 3F-13F.
25. Angaran DM, Schultz NJ, Tschida VH. Esmolol hydrochloride: an ultrashortacting, beta-adrenergic blocking agent. Clin Pharm 1986; 5: 288-303.